<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04244409</url>
  </required_header>
  <id_info>
    <org_study_id>WombTransplantUK</org_study_id>
    <nct_id>NCT04244409</nct_id>
  </id_info>
  <brief_title>INvestigational Study Into Transplantation of the Uterus</brief_title>
  <acronym>INSITU</acronym>
  <official_title>INvestigational Study Into Transplantation of the Uterus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Womb Transplant UK</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oxford University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Imperial College Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Womb Transplant UK</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study on cohort of 10 women undergoing uterine transplantation using deceased
      donors
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 18, 2019</start_date>
  <completion_date type="Anticipated">February 18, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 18, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transplant success rate</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Mayer-Rokitansky-Kuster Syndrome</condition>
  <condition>Asherson's Syndrome</condition>
  <condition>Postpartum Hemorrhage</condition>
  <condition>Cervical Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Women with absolute uterine factor infertility
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female

          2. Age - 24-38 (or 40 if eggs frozen &lt;38)

          3. AUFI

               1. Normal length vagina

               2. No renal pathology

          4. BMI &lt;30kg/m2

          5. ASA grade I

          6. Meet psychological criteria

          7. Meet HFEA criteria for IVF

          8. Eligible for NHS treatment

          9. Speak fluent English

        Exclusion Criteria:

          1. Unsuccessful oocyte retrieval (&lt;10 good quality embryos)

          2. Previous multiple/significant surgeries

          3. Severe endometriosis

          4. Cancer patients &lt;5 years in remission

          5. Previous living childbirth, adopted child or child born through surrogacy

          6. HIV or Hepatitis B / C positive

          7. Skin or intestinal neovagina
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Hammersmith Hospital, Imperial College NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Jones, MRCOG</last_name>
      <phone>02033131000</phone>
      <email>benjamin.jones@nhs.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Imperial College Healthcare NHS Trust</investigator_affiliation>
    <investigator_full_name>Ben Jones</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Gynaecology</keyword>
  <keyword>Immunosuppression</keyword>
  <keyword>In-vitro Fertilisation</keyword>
  <keyword>Infertility</keyword>
  <keyword>MRKH</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Transplantation</keyword>
  <keyword>Uterus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postpartum Hemorrhage</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

